arrow
P

Pascal Marchand

Nantes Universite
H指数:20
被引数:1,312

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pharmacophore-guided optimization of the hit compound CTN1122 in the design of promising imidazo[1; 2-a]pyrazine derivatives targeting the casein kinase 1 for antileishmanial therapy

以药效团为指导对靶向酪蛋白激酶1的抗利什曼原虫治疗中具有潜力的咪唑并[1; 2-a]吡嗪衍生物进行先导化合物CTN1122的优化设计

2025-08-140
PRE
2-Aminothiophene Derivatives-New Drug Candidates Against Leishmaniasis: Drug Design, Synthesis, Pharmacomodulation, and Antileishmanial Activity
2025-01-170
OAAI
Investigating the C2 Modulation of the Imidazo[1,2-a]pyrazine-Based Hit Compound CTN1122: Synthesis, in vitro Antileishmanial Activity, Cytotoxicity and Casein Kinase 1 Inhibition

研究基于咪唑并 [1,2-a] 吡嗪的命中化合物CTN1122的C2调节: 合成,体外抗利什曼蛋白活性,细胞毒性和酪蛋白激酶1抑制

2025-01-060
PRE
29th Annual GP2A Medicinal Chemistry Conference

第29届GP2A药物化学年会

2021-12-070
OAAI
In vitro identification of imidazo[1,2-a]pyrazine-based antileishmanial agents and evaluation of L. major casein kinase 1 inhibition
2021-01-0117
OAAI
Biological Evaluation of Arylsemicarbazone Derivatives as Potential Anticancer Agents
2019-11-177
OAAI